Royal Bank of Canada’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-118,838
| Closed | -$369K | – | 8343 |
|
|
2021
Q4 | $369K | Buy |
118,838
+110,626
| +1,347% | +$372K | ﹤0.01% | 4748 |
|
|
2021
Q3 | $29K | Buy |
8,212
+1,656
| +25% | +$6.25K | ﹤0.01% | 6496 |
|
|
2021
Q2 | $24K | Buy |
6,556
+1,833
| +39% | +$6.47K | ﹤0.01% | 6492 |
|
|
2021
Q1 | $18K | Buy |
+4,723
| New | +$19.5K | ﹤0.01% | 6507 |
|
|
2020
Q4 | – | Sell |
-750
| Closed | -$3K | – | 7551 |
|
|
2020
Q3 | $3K | Sell |
750
-5,085
| -87% | -$21.6K | ﹤0.01% | 6283 |
|
|
2020
Q2 | $25K | Sell |
5,835
-3,017
| -34% | -$13.6K | ﹤0.01% | 5502 |
|
|
2020
Q1 | $33K | Buy |
8,852
+8,002
| +941% | +$39.3K | ﹤0.01% | 5346 |
|
|
2019
Q4 | $6K | Sell |
850
-7,150
| -89% | -$42K | ﹤0.01% | 6329 |
|
|
2019
Q3 | $34K | Buy |
8,000
+7,358
| +1,146% | +$31.4K | ﹤0.01% | 5281 |
|
|
2019
Q2 | $3K | Buy |
+642
| New | +$2.99K | ﹤0.01% | 6538 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | – | – | 7570 |
|
|
2018
Q3 | $0 | Sell |
11
-989
| -99% | -$2.78K | ﹤0.01% | 7260 |
|
|
2018
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 6222 |
|
|
2018
Q1 | $2K | Sell |
1,000
-89
| -8% | -$208 | ﹤0.01% | 6168 |
|
|
2017
Q4 | $3K | Sell |
1,089
-313
| -22% | -$865 | ﹤0.01% | 6245 |
|
|
2017
Q3 | $4K | Buy |
1,402
+1,002
| +251% | +$3.05K | ﹤0.01% | 6495 |
|
|
2017
Q2 | $1K | Sell |
400
-14
| -3% | -$30 | ﹤0.01% | 6520 |
|
|
2017
Q1 | $1K | Buy |
414
+14
| +4% | +$27 | ﹤0.01% | 6555 |
|
|
2016
Q4 | $1K | Sell |
400
-2,000
| -83% | -$4.08K | ﹤0.01% | 6598 |
|
|
2016
Q3 | $6K | Buy |
2,400
+1,745
| +266% | +$4.43K | ﹤0.01% | 5946 |
|
|
2016
Q2 | $2K | Buy |
655
+255
| +64% | +$704 | ﹤0.01% | 6200 |
|
|
2016
Q1 | $1K | Sell |
400
-53,607
| -99% | -$198K | ﹤0.01% | 6295 |
|
|
2015
Q4 | $258K | Buy |
54,007
+52,471
| +3,416% | +$297K | ﹤0.01% | 4343 |
|
|
2015
Q3 | $9K | Sell |
1,536
-13,706
| -90% | -$101K | ﹤0.01% | 5967 |
|
|
2015
Q2 | $121K | Buy |
15,242
+4,027
| +36% | +$34.6K | ﹤0.01% | 4714 |
|
|
2015
Q1 | $118K | Buy |
11,215
+3,289
| +41% | +$44.9K | ﹤0.01% | 4533 |
|
|
2014
Q4 | $95K | Buy |
+7,926
| New | +$120K | ﹤0.01% | 4760 |
|
|
2014
Q2 | – | Sell |
-1,000
| Closed | -$8K | – | 6490 |
|
|
2014
Q1 | $8K | Hold |
1,000
| – | – | ﹤0.01% | 5505 |
|
|
2013
Q4 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 5588 |
|
|
2013
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 5658 |
|
|
2013
Q2 | $4K | Buy |
+1,000
| New | +$4.69K | ﹤0.01% | 5526 |
|
Other funds holding BDSI
Royal Bank of Canada's BDSI Position: Q1 2022 in Review
Royal Bank of Canada sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 118,838 shares — an estimated $369K sold.
Royal Bank of Canada first reported a position in BDSI in Q2 2013 and held it in 30 quarters. The position peaked at $369K in Q4 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Royal Bank of Canada reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Royal Bank of Canada sold 118,838 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $369K.
- Royal Bank of Canada first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 30 quarters.
- Royal Bank of Canada's BioDelivery Sciences International, Inc. position peaked at $369K in Q4 2021.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Royal Bank of Canada's 13F filing for Q1 2022, filed 16 May 2022.